期刊文献+

miR-195靶向TLR4并阻断NF-κB通路抑制肝癌细胞HepG2增殖和转移 被引量:6

miR-195 targets TLR4 to inhibit proliferation and metastasis of liver cancer cells via blocking NF-κB pathway
下载PDF
导出
摘要 目的:探讨miR-195/Toll样受体4(TLR4)分子轴通过调控NF-κB通路对肝癌细胞增殖、侵袭和迁移的影响。方法:收集2016年3月至2017年1月昆明医科大学第二附属医院外科手术切除的25例肝癌组织以及对应的癌旁组织标本;肝癌HepG2细胞培养完成后分为4组,即对照组(NC)、miR-195 mimic组(miR-195组)、TLR4敲降组(si-TLR4组)和miR-195 inhibitor联合TLR4敲降组(si-TLR4+miR-195 inhibitor组)。采用q PCR检测miR-195在肝癌组织和细胞系中的表达水平;采用CCK-8法检测上述各组细胞的增殖活力,Transwell法检测各组细胞的侵袭能力,划痕愈合实验检测细胞迁移能力,双荧光素酶报告基因验证miR-195和TLR4的靶向调控关系,WB检测TLR4和NF-κB p65蛋白的表达。结果:miR-195在肝癌组织中低表达(P<0.01)。相比于人肝上皮细胞(THLE-3),miR-193在肝癌细胞系(HepG2和Huh-7)中低表达(P<0.01),且HepG2细胞中的表达水平最低。过表达miR-195后HepG2细胞增殖活力明显低于对照组(P<0.01),穿膜细胞明显减少(P<0.01),HepG2细胞迁移能力明显下调(P<0.01)。过表达miR-195可明显抑制TLR4蛋白的表达水平(P<0.05),且TLR4与miR-195的表达呈负相关(R^2=0.602,P<0.0001)。过表达miR-195可靶向下调TLR4并阻断NF-κB通路抑制HepG2细胞增殖、侵袭和迁移能力(P<0.05或P<0.01)。结论:miR-195能够抑制HepG2细胞增殖、侵袭及迁移能力,其机制可能与靶向调控TLR4并阻断NF-κB通路影响细胞生物学行为有关。 Objective:To explore the effect of miR-195/TLR4 axis on the proliferation,invasion and migration of liver cancer cells via regulating NF-κB pathway.Methods:Twenty-five pairs of liver cancer tissues and corresponding adjacent tissues surgically resected at the Second Affiliated Hospital of Kunming Medical University from March 2016 to January 2017 were collected for this study.Liver cancer HepG2 cells were cultured and then randomly divided into four groups:control group(NC),miR-195 mimic group(miR-195),TLR4 knockdown group(si-TLR4),and miR-195 inhibitor combined with TRL4 knockdown group(si-TLR4+miR-195 inhibitor).qRTPCR was used to detect the expression of miR-195 in liver cancer tissues and cell lines.CCK-8 assay was used to evaluate the cell viability of each group.Transwell and Wound healing assay were applied to detect the invasion and migration ability of HepG2 cells,respectively.Dual-luciferase reporter gene assay was used to verify the targeted regulation of TLR4 by miR-195.WB was applied to analyze the protein expressions of TLR4 and NF-κB p65.Results:miR-195 was down-regulated in the liver cancer tissues compared with adjacent tissues(P<0.01).Compared with human hepatic epithelial cells(THLE-3),the expression of miR-193 in liver cancer cell lines(HepG2 and Huh-7)was down-regulated(P<0.01),and the expression level in HepG2 cells was the lowest.The proliferation,invasion and migration of HepG2 cells was significantly suppressed after over-expression of miR-195(all P<0.01).Moreover,over-expression of miR-195 significantly down-regulated TLR4 protein expression(P<0.05),and TLR4 was negatively correlated with miR-195(R^2=0.602,P<0.0001).Furthermore,miR-195 over-expression inhibited proliferation,invasion and migration of HepG2 cells by targeting TLR4 expression and blocking NF-κB pathway(P<0.05 or P<0.01).Conclusion:miR-195 over-expression can inhibit the proliferation,invasion and migration of HepG2 cells.The mechanism may be related with targeting TLR4 and blocking the NF-κB pathway to affect cell biol
作者 陈鹏 崔锐 梁鸿飞 陈晨 CHEN Peng;CUI Rui;LIANG Hongfei;CHEN Chen(Department of Hepatic-Biliary-Pancreatic Surgery,The Second Affiliated Hospital of Kunming Medical University,Kunming 650101,Yunnan,China;Department of Ophthalmology,The Second People's Hospital of Yunnan Province,Kunming 650021,Yunnan,China)
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2019年第5期550-556,共7页 Chinese Journal of Cancer Biotherapy
基金 云南省科技计划项目-面上项目(No.2014FB194 2016FB133) 云南省应用基础研究(昆明医科大学联合专项)[No.2017FE467(-182)]~~
关键词 肝癌 HEPG2细胞 miR-195 TOLL样受体4 NF-ΚB通路 liver cancer HepG2 cell miR-195 Toll-like receptors 4(TLR4) NF-κB pathway
  • 相关文献

参考文献1

二级参考文献14

  • 1Oyama T, Ran S, Ishida T, et al. Vascular endothelial factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells. J Immunol, 1998,160:1224-1232. 被引量:1
  • 2Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med, 1996, 2:1096-1103. 被引量:1
  • 3Nakashima M, Sonoda K, Watanabe A. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med, 1999, 5:938-942. 被引量:1
  • 4Kiertscher SM, Luo J, Dubinett SM, et al. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol, 2000,164:1269-1276. 被引量:1
  • 5Gabrilovich DI, Ciernik IF, Carbone DP. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol, 1996,170:101-110. 被引量:1
  • 6Gabrilovich DI, Corak J, Ciernik IF, et al. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res, 1997,3:483-490. 被引量:1
  • 7Pardoll DM. Cancer vaccine. Nat Med, 1998, 4(Suppl):525-531. 被引量:1
  • 8Marincola FM, Jaffee EM, Hicklin DJ, et al. Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance. Adv Immunol, 2000, 74:181. 被引量:1
  • 9Paillard F. Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approaches. Hum Gene Ther, 2000,11:657-658. 被引量:1
  • 10Fong L. Dendritic cells in cancer immunotherapy. Annu Rev Immunol, 2000,18:245-273. 被引量:1

共引文献5

同被引文献39

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部